PL3364947T3 - Wodna kompozycja zawierająca dantrolen - Google Patents

Wodna kompozycja zawierająca dantrolen

Info

Publication number
PL3364947T3
PL3364947T3 PL16784877T PL16784877T PL3364947T3 PL 3364947 T3 PL3364947 T3 PL 3364947T3 PL 16784877 T PL16784877 T PL 16784877T PL 16784877 T PL16784877 T PL 16784877T PL 3364947 T3 PL3364947 T3 PL 3364947T3
Authority
PL
Poland
Prior art keywords
dantrolene
aqueous composition
aqueous
composition
Prior art date
Application number
PL16784877T
Other languages
English (en)
Inventor
Hervé Jean SCHWEBEL
Vincent ADAMO
Original Assignee
B. Braun Melsungen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B. Braun Melsungen Ag filed Critical B. Braun Melsungen Ag
Publication of PL3364947T3 publication Critical patent/PL3364947T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41661,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
PL16784877T 2015-10-20 2016-10-19 Wodna kompozycja zawierająca dantrolen PL3364947T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP15190601 2015-10-20
EP16174999 2016-06-17
PCT/EP2016/075086 WO2017067980A1 (en) 2015-10-20 2016-10-19 Aqueous composition comprising dantrolene
EP16784877.9A EP3364947B1 (en) 2015-10-20 2016-10-19 Aqueous composition comprising dantrolene

Publications (1)

Publication Number Publication Date
PL3364947T3 true PL3364947T3 (pl) 2022-02-07

Family

ID=57184442

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16784877T PL3364947T3 (pl) 2015-10-20 2016-10-19 Wodna kompozycja zawierająca dantrolen

Country Status (11)

Country Link
US (2) US11844782B2 (pl)
EP (1) EP3364947B1 (pl)
JP (2) JP7409772B2 (pl)
KR (1) KR20180066239A (pl)
CN (2) CN118078742A (pl)
CA (1) CA3002113C (pl)
ES (1) ES2898425T3 (pl)
MX (1) MX2018004033A (pl)
PL (1) PL3364947T3 (pl)
RU (1) RU2729043C2 (pl)
WO (1) WO2017067980A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10532102B2 (en) 2016-08-19 2020-01-14 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition and methods of uses
EP3360539A1 (de) * 2017-02-09 2018-08-15 SapioTec GmbH Pharmazeutische formulierung
MX2020007270A (es) 2017-09-27 2020-08-17 Novartis Ag Formulacion parenteral que comprende siponimod.
JPWO2020049670A1 (ja) 2018-09-06 2021-08-12 シミックホールディングス株式会社 ダントロレン水性製剤及びその調製方法
WO2021044608A1 (ja) * 2019-09-06 2021-03-11 シミックホールディングス株式会社 ダントロレン水性製剤及びその調製方法
WO2022169582A1 (en) * 2021-02-05 2022-08-11 Uswm, Llc Compositions and methods for clear concentrated parenteral delivery of dantrolene therapeutic agents
MX2023013033A (es) 2021-05-06 2023-11-16 Spepharm Ag Formulaciones farmaceuticas.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822011B2 (ja) * 1976-08-10 1983-05-06 山之内製薬株式会社 安定なダントロレンナトリウムの製剤
US6407079B1 (en) 1985-07-03 2002-06-18 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
JPH06263636A (ja) * 1993-03-12 1994-09-20 Kiyoshi Kataoka 脳または高次神経疾患治療剤
WO1999062958A1 (en) 1998-05-29 1999-12-09 Janssen Pharmaceutica N.V. Acylated alkylated cyclodextrin derivatives and their use as carriers for medicaments
US7758890B2 (en) 2001-06-23 2010-07-20 Lyotropic Therapeutics, Inc. Treatment using dantrolene
JP2003321364A (ja) * 2002-05-07 2003-11-11 Eisai Co Ltd シクロデキストリンにより可溶化及び安定化された抗腫瘍剤含有組成物
JP2006199588A (ja) * 2003-05-06 2006-08-03 Senju Pharmaceut Co Ltd オキサゾリジノン誘導体含有水性液剤
WO2006016530A1 (ja) * 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
JPWO2006134877A1 (ja) * 2005-06-13 2009-01-08 武田薬品工業株式会社 注射剤
ITMI20051999A1 (it) * 2005-10-21 2007-04-22 Eratech S R L Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
KR100917809B1 (ko) * 2006-05-22 2009-09-18 에스케이케미칼주식회사 우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물
EP2583670A1 (en) 2007-10-09 2013-04-24 US Worldmeds LLC Co-solvent compositions and methods for improved delivery of dantrolene therapeutic agents
WO2009104080A2 (en) * 2008-02-20 2009-08-27 Targia Pharmaceuticals Cns pharmaceutical compositions and methods of use
US20120040970A1 (en) * 2009-04-27 2012-02-16 Al-Ghananeem Abeer M Intranasal delivery system for dantrolene
JP5320413B2 (ja) 2011-01-18 2013-10-23 本田技研工業株式会社 自動変速機の制御装置
JP6263636B2 (ja) 2014-01-13 2018-01-17 孫 松華Sun, Songhua 錯化剤、その製造方法及び用途

Also Published As

Publication number Publication date
JP2023154096A (ja) 2023-10-18
RU2018117935A3 (pl) 2020-01-21
JP2018531268A (ja) 2018-10-25
JP7409772B2 (ja) 2024-01-09
RU2729043C2 (ru) 2020-08-04
MX2018004033A (es) 2018-07-06
WO2017067980A1 (en) 2017-04-27
US11844782B2 (en) 2023-12-19
RU2018117935A (ru) 2019-11-21
EP3364947B1 (en) 2021-09-15
US20180256548A1 (en) 2018-09-13
US20240091198A1 (en) 2024-03-21
ES2898425T3 (es) 2022-03-07
CA3002113A1 (en) 2017-04-27
CN108366963A (zh) 2018-08-03
CA3002113C (en) 2024-05-28
EP3364947A1 (en) 2018-08-29
KR20180066239A (ko) 2018-06-18
CN118078742A (zh) 2024-05-28

Similar Documents

Publication Publication Date Title
HK1244689A1 (zh) 水性眼科組合物
GB201512030D0 (en) Composition
GB201505527D0 (en) Composition
GB201521507D0 (en) Composition
PL3364947T3 (pl) Wodna kompozycja zawierająca dantrolen
GB201506827D0 (en) Composition
GB201515640D0 (en) Composition
GB201506830D0 (en) Composition
GB201506829D0 (en) Composition
SG11201704740WA (en) Aqueous composition
GB201506825D0 (en) Composition
GB201517546D0 (en) Composition
GB201522603D0 (en) Composition
GB201506828D0 (en) Composition
GB201518348D0 (en) Composition
GB201514585D0 (en) Composition
GB201511697D0 (en) Composition
GB201509044D0 (en) Composition
GB201505520D0 (en) Composition
GB201504665D0 (en) Composition
GB201504307D0 (en) Composition
SG11201702202UA (en) Aqueous composition
GB201519327D0 (en) Composition
GB201515639D0 (en) Composition
GB201508722D0 (en) Composition